newsfilter
← Latest News
GlobeNewswire·

VERAXA Biotech Initiates Cell Line Development with ATUM to Advance its Lead BiTAC®-TCE Program

ZURICH, SWITZERLAND – July 02, 2026 -- VERAXA Biotech AG (NASDAQ:VRXA, "VERAXA")), an emerging leader in designing novel cancer therapies, today announced the initiation of cell line development for its lead